ARCHIVES

Drugs and Targets: Cyramza approved in metastatic stomach cancer

This article is from The Cancer Letter archive.

Vol. 40 No. 42 | November 7, 2014

Download PDF Visit The Full Archive

Related Articles

DCPC Board To hear To Hear Concept for Contract to Develop Program For Heavy Smokers

January 11, 1985

Combined analysis moves Herceptin to adjuvant setting in breast cancer.

May 27, 2005

Randomized Trials Discovered Roles For Newly Approved Nexavar and Sutent.

February 24, 2006

Murphy Puts RPMI On Record

July 22, 1977

NCI Planning Phase III Study Of Avastin For Metastatic Colorectal Cancer

June 27, 2003

House, Senate Agree On $1.91 Billion NCI Appropriations

September 30, 1994